Study type: In vivo/preclinical · Status: Verified against declared source

MOTS-c mimics exercise to combat diabetic liver fibrosis by targeting Keap1-Nrf2-Smad2/3.

Scientific reports · 2025

Study scale: Not reported

Abstract only: Open source record

Product or molecular entity relationships

MOTS-c: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

Plain-language verified summary

Question

Not reported in the reviewed source.

Methods

Not reported in the reviewed source.

Scale or participants

Not reported in the reviewed source.

Key findings

Liver fibrosis is a common complication of T2DM(Type 2 diabetes mellitus).

Limitations and uncertainty

Liver fibrosis is a common complication of T2DM(Type 2 diabetes mellitus).

Verified against declared source. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.